Virginia Commonwealth University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).
Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.
Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
558 total, page 6 of 12
Piloting a Novel Intuitive Eating Intervention for College Women With Disordered Eating
NCT03612661
Maladaptive Adipose Tissue Activity in Cancer
NCT03621124
Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
NCT03489161
Music Distraction and Its Influence on Anesthetic Requirements During Elective Knee Surgery
NCT03486106
Health IT Generated PROs to Improve Outcomes in Cirrhosis
NCT03564626
Feasibility and Validation of a Standard Phenotyping Assessment Battery
NCT03495869
Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial
NCT03472495
RVA Breathes: A Richmond City Collaboration to Reduce Pediatric Asthma Disparities
NCT03297645
The Influence of Electronic (ECIG) Heater Resistance on ECIG Acute Effects
NCT03496116
Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake
NCT03558022
Treatment of Acute Pericarditis With Anakinra
NCT03224585
Pharmacist-driven CGM Use in the Uninsured Population
NCT03477838
Stress Reduction Training for Emotion Regulation and Well-Being
NCT03485807
The Impact of Physical (In)Activity on Sleep Quality
NCT03514953
Theta Burst Stimulation to Promote Motor Re-education in Tetraplegia
NCT03277521
Promoting Patient Engagement in Clinical Preventive Services: Evaluating the Use of Healthfinder
NCT03462186
A Multiple Baseline Design Study to Investigate the Effectiveness of OT-SI Using an Intensive Intervention Model
NCT03355417
Assessment of Two New Electronic Cigarettes in Cigarette Smokers
NCT03435562
Intervention to Promote Survivor Resilience and Adjustment: Efficacy and Sustainability
NCT03421964
Evaluating the Feasibility of a Stepped-care Approach to Treating Adolescents With Binge and Loss of Control Eating
NCT03404713
Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)
NCT02878798
Mindfulness Practices for Healthcare Professional Trainees
NCT03403335
In-Home Adjustment of New Spinal Cord Injury Caregivers
NCT03244098
The Role of High Intensity Interval Training in the Treatment of Adolescent Obesity
NCT03361644
An Interprofessional Intervention to Reduce Smoking Rates
NCT03380910
sPLA2 in EBC During Acute Chest Syndrome
NCT03250585
Pilot for a Community Pharmacy Service Model: Impact of a Pharmacist Monitored Patient Blood Pressure Readings
NCT03323840
An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients
NCT03722264
Myocardial Perfusion and Fibrosis in Cancer Survivors
NCT03191461
Diabetes Engagement and Activation Platform
NCT02957721
Unsaturated Fatty Acids Enriched-diet to Improve Cardiorespiratory Fitness, Metabolic Flexibility and Glucose Tolerance in Obese Patients
NCT03310099
Effects of Liothyronine on Energy Expenditure and Cardiovascular Function
NCT03098433
Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory
NCT03323450
SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx
NCT03220854
Vitamin C in Atrial Fibrillation Ablation
NCT03148236
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
NCT03141008
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
NCT03317587
Impact of Cognitive Rehab and Physical Activity on Cognition in Patients With Metastatic Brain Tumors Undergoing RT
NCT03096431
Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients
NCT03249194
Supervised Fitness Program for Adults With Cerebral Palsy
NCT03218774
Effect of Sensory Adapted Dental Environment on Dental Anxiety of Children With Intellectual and Developmental Disabilities
NCT03218462
Alternative Doffing Strategies to Prevent Healthcare Worker Self-Contamination When Using Personal Protective Equipment (PPE)
NCT03192553
Oral Fecal Transplant in Cirrhosis
NCT03152188
Addressing Modifiable Breast Cancer Risk Factors With Project CONECT
NCT02871388
Effect of Prevention Education in Caries Formation in Pediatric Patients With Leukemia
NCT03281746
Examining the Effect of Mental Health Disorders on Vascular Function and Exercise Tolerance
NCT03216980
Effect of a 9-Month Internship Intervention for Military Dependents With ASD
NCT04001790
Anxiety, Mood, and Health Behaviors in Young Adults
NCT03128437
Noninvasive NAVA Versus NIPPV in Low Birthweight Premature Infants
NCT03137225
Effects of an OT Workstation Intervention on Knowledge, Self-efficacy, and Habit Formation
NCT03174262
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 65 |
| Phase 3 | 13 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the Virginia Commonwealth University pipeline
77 recruiting of 558 indexed (14% open); 380 completed (68%).
Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Virginia Commonwealth University: open-pipeline peers nationwide
Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 558 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Ohio State University · 552 trials · 21% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Lindenwood University · 14% recruiting · 29 trials
- BeiGene · 14% recruiting · 65 trials
- Reproductive Medicine Associates of New Jersey · 14% recruiting · 51 trials
- University of Cincinnati · 14% recruiting · 245 trials
Related
What to do with this Virginia Commonwealth University page
558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.
- 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.